descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1993 English Publisher:Elsevier BVJournal:Chest, volume 103, pages 313-314 (issn: 0012-3692,

Authors: James L. Breeling; Louis Weinstein;

doi: 10.1378/chest.103.1.313

pmid: 8380267

Pulmonary Sporotrichosis Treated With Itraconazole

- Summary
- Subjects
- Metrics

Abstract

A 62-year-old woman had chronic cavitary pulmonary sporotrichosis refractory to medical management over an 8-year period. She was treated with oral itraconazole and had an apparent microbiologic and clinical response; however, the patient succumbed to progressive pulmonary hypertension. The early use of oral itraconazole for treatment of pulmonary sporotrichosis is advocated.

Related Organizations

Brigham and Women's Faulkner Hospital
United States

Keywords

Antifungal Agents, Lung Diseases, Fungal, Potassium Iodide, Middle Aged, Sporotrichosis, Ketoconazole, Amphotericin B, Humans, Female, Itraconazole

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	15
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average